The use of intravitreal bevacizumab appears to be safe in preterm infants for treatment of retinopathy of prematurity, according to a long-term multicenter study.
Retina Global is a US based 501(c)(3) nonprofit that is focused on finding sustainable solutions to the ever-increasing issues with retinal diseases in underserved areas around the world.
Wednesday, July 15, 2015
Saturday, July 4, 2015
NIH research points to microglia as potential therapeutic target in Retinitis Pigmentosa
Spider-like cells inside the brain, spinal cord and eye hunt for invaders, capturing and then devouring them. These cells, called microglia, often play a beneficial role by helping to clear trash and protect the central nervous system against infection. But a new study by researchers at the National Eye Institute (NEI) shows that they also accelerate damage wrought by blinding eye disorders, such as retinitis pigmentosa.
Subscribe to:
Posts (Atom)